KR101578949B1 - 가요성 측쇄를 가지는 항말라리아 화합물 - Google Patents

가요성 측쇄를 가지는 항말라리아 화합물 Download PDF

Info

Publication number
KR101578949B1
KR101578949B1 KR1020107010151A KR20107010151A KR101578949B1 KR 101578949 B1 KR101578949 B1 KR 101578949B1 KR 1020107010151 A KR1020107010151 A KR 1020107010151A KR 20107010151 A KR20107010151 A KR 20107010151A KR 101578949 B1 KR101578949 B1 KR 101578949B1
Authority
KR
South Korea
Prior art keywords
delete delete
ethyl
compound
diamino
propoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020107010151A
Other languages
English (en)
Korean (ko)
Other versions
KR20100094459A (ko
Inventor
봉코츠 타느촘푸
용유스 유타봉
티라유트 비라이반
펜치트 치트눔수브
차와니 통판창
수마리 캄촌웡파이산
데이비드 마트헤스
리비아 비바스
디룬돈 유바니야마
수잔 차르만
월리암 차르만
산자이 바부 카티야르
Original Assignee
엠엠브이 메디슨즈 포 말라리아 벤처
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엠엠브이 메디슨즈 포 말라리아 벤처 filed Critical 엠엠브이 메디슨즈 포 말라리아 벤처
Publication of KR20100094459A publication Critical patent/KR20100094459A/ko
Application granted granted Critical
Publication of KR101578949B1 publication Critical patent/KR101578949B1/ko
Assigned to 내셔널 사이언스 앤드 테크놀로지 디벨로프먼트 에이전시 reassignment 내셔널 사이언스 앤드 테크놀로지 디벨로프먼트 에이전시 권리의 전부이전등록 Assignors: 엠엠브이 메디슨즈 포 말라리아 벤처
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020107010151A 2007-10-08 2008-10-08 가요성 측쇄를 가지는 항말라리아 화합물 Active KR101578949B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97837507P 2007-10-08 2007-10-08
US60/978,375 2007-10-08

Publications (2)

Publication Number Publication Date
KR20100094459A KR20100094459A (ko) 2010-08-26
KR101578949B1 true KR101578949B1 (ko) 2015-12-18

Family

ID=40534843

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107010151A Active KR101578949B1 (ko) 2007-10-08 2008-10-08 가요성 측쇄를 가지는 항말라리아 화합물

Country Status (22)

Country Link
US (1) US8530491B2 (https=)
EP (2) EP2194985B1 (https=)
JP (1) JP5603775B2 (https=)
KR (1) KR101578949B1 (https=)
CN (1) CN101820879B (https=)
AU (1) AU2008310898B2 (https=)
BR (1) BRPI0818618B8 (https=)
CA (1) CA2700880C (https=)
CY (1) CY1121598T1 (https=)
DK (1) DK2194985T3 (https=)
ES (1) ES2727015T3 (https=)
HR (1) HRP20190589T1 (https=)
HU (1) HUE044398T2 (https=)
LT (1) LT2194985T (https=)
MX (1) MX2010003739A (https=)
PL (1) PL2194985T3 (https=)
PT (1) PT2194985T (https=)
RU (1) RU2485107C2 (https=)
SI (1) SI2194985T1 (https=)
TR (1) TR201904913T4 (https=)
UA (1) UA105759C2 (https=)
WO (1) WO2009048957A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012108845A1 (en) * 2011-02-09 2012-08-16 National Science And Technology Development Agency A bacterial surrogate for testing of antimalarials: thya knockout and fola knockout bacteria for testing of inhibition of malarial dihydrofolate reductase-thymidylate synthase
WO2012121682A2 (en) * 2011-03-10 2012-09-13 National Science And Technology Development Agency Anti-folate antimalarials with dual-binding modes and their preparation
US10011842B2 (en) 2013-09-30 2018-07-03 National Science And Technology Development Agency Escherichia coli cell line with thyA knockout, folA knockout, and one or both of folP knockout, and folK knockout
CN104593406A (zh) * 2015-01-08 2015-05-06 山西医科大学 pIRES/TgDHFR-TS真核表达重组质粒及其构建和应用
US11028072B2 (en) 2015-09-23 2021-06-08 National Science And Technology Development Agency 2,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against Plasmodium falciparum
CN106083742A (zh) * 2016-05-31 2016-11-09 广东工业大学 一种2,4‑二胺基喹唑啉衍生物及其制备方法和应用
WO2021155748A1 (en) * 2020-02-04 2021-08-12 Tsinghua University Inhibitors of malarial and plasmodium falciparum hexose transporter and uses thereof
CN112961106A (zh) * 2021-03-13 2021-06-15 德州学院 一种4-羟基-6氯喹啉合成新工艺
EP4438596A1 (en) * 2023-03-28 2024-10-02 Université de Lille Diaminopyrimidine derivatives as hdac and dhfr dual-targeting inhibitors and use thereof in preventing and treating malaria
WO2025053796A1 (en) * 2023-09-04 2025-03-13 National Science And Technology Development Agency Hybrid molecules between pyrimidine derivatives and idasanutlin
CN117263804A (zh) * 2023-09-07 2023-12-22 中国烟草总公司郑州烟草研究院 邻羟基苯丙酸酯及其制备方法和应用
CN117025299A (zh) * 2023-09-07 2023-11-10 中国烟草总公司郑州烟草研究院 一种烟用豆香香基模块、香精和卷烟

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
GB1546937A (en) * 1976-07-29 1979-05-31 Beecham Group Ltd 2,4-diaminopyrimidine derivatives
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
GB2086386B (en) * 1980-10-27 1984-01-18 May & Baker Ltd Pyrimidine derivatives
OA07362A (fr) 1980-10-27 1984-06-30 May & Baker Ltd Dérivés de la pyrimidine, leur procédé de préparation et les compositions les contenant.
US5322858A (en) 1992-02-14 1994-06-21 Jacobus Pharmaceutical Co. Inc. N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
IL146566A0 (en) * 1999-05-24 2002-07-25 Sankyo Co A pharmaceutical composition containing anti-fas antibody
IT1317826B1 (it) * 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
US7371758B2 (en) * 2003-03-13 2008-05-13 National Science & Technology Development Agency Antimalarial pyrimidine derivatives and methods of making and using them

Also Published As

Publication number Publication date
WO2009048957A8 (en) 2010-04-22
US8530491B2 (en) 2013-09-10
JP5603775B2 (ja) 2014-10-08
PT2194985T (pt) 2019-05-30
EP3546452A1 (en) 2019-10-02
MX2010003739A (es) 2010-04-21
AU2008310898A1 (en) 2009-04-16
EP2194985A4 (en) 2012-01-25
HRP20190589T1 (hr) 2019-05-31
CA2700880C (en) 2016-03-08
RU2010117193A (ru) 2011-11-20
KR20100094459A (ko) 2010-08-26
SI2194985T1 (sl) 2019-04-30
BRPI0818618B8 (pt) 2023-04-25
ES2727015T3 (es) 2019-10-11
TR201904913T4 (tr) 2019-05-21
CY1121598T1 (el) 2020-07-31
US20090099220A1 (en) 2009-04-16
LT2194985T (lt) 2019-04-10
WO2009048957A1 (en) 2009-04-16
UA105759C2 (uk) 2014-06-25
AU2008310898B2 (en) 2014-05-08
EP2194985A1 (en) 2010-06-16
CN101820879B (zh) 2013-01-02
EP2194985B1 (en) 2019-02-20
JP2010540666A (ja) 2010-12-24
PL2194985T3 (pl) 2019-12-31
HUE044398T2 (hu) 2019-10-28
BRPI0818618B1 (pt) 2020-03-03
RU2485107C2 (ru) 2013-06-20
BRPI0818618A2 (pt) 2015-08-04
CN101820879A (zh) 2010-09-01
CA2700880A1 (en) 2009-04-16
DK2194985T3 (da) 2019-05-20

Similar Documents

Publication Publication Date Title
KR101578949B1 (ko) 가요성 측쇄를 가지는 항말라리아 화합물
JP6075621B2 (ja) 新規複素環誘導体およびそれらを含有する医薬組成物
EP1704145B1 (en) Selective kinase inhibitors
KR20090026264A (ko) 측쇄에 스피로 고리 구조를 갖는 신규 인다졸 유도체
US20100152213A1 (en) Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof
WO2016210331A1 (en) Treatment of infectious diseases with glucose uptake inhibitors
KR102374033B1 (ko) 특정 단백질 키나제 억제제
US9416124B2 (en) Substituted 2-alkyl-1-OXO-N-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
US7855288B2 (en) Pyrrolo [1,2-d] [1,2-4] triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases
CZ12097A3 (en) Trifluoromethylquinolinecarboxylic acid derivatives and pharmaceutical composition containing thereof
HK40014875A (en) Antimalarial compounds with flexible side-chains
CZ305457B6 (cs) Pyrimidinové sloučeniny inhibující tvorbu oxidu dusnatého a prostaglandinu E2, způsob výroby a použití
US7371758B2 (en) Antimalarial pyrimidine derivatives and methods of making and using them
HK40083035B (zh) Parp7抑制剂及其用途
US20230271943A1 (en) Compounds as dhodh inhibitors
CN119948032A (zh) 呋喃并嘧啶衍生物
KR100559261B1 (ko) 2Ｈ-피리도[4,5-ｅ][1,2,4]트리아진-3-일리덴-시안아마이드의 유도체 및 그의 제조방법
Peréz-Pérez et al. Novel antiviral compounds
AU2005203919A1 (en) Selective kinase inhibitors
HK1199443B (en) Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahyd roisoquinoline-4-carboxamides for antimalarial therapies

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100507

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130924

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141230

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150730

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20141230

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20151007

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20150730

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20151202

Appeal identifier: 2015101005910

Request date: 20151007

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20151007

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20151007

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20150227

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20130924

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20151202

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20151109

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20151214

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20151214

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20181206

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20181206

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20191205

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20191205

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20201204

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20201204

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20211202

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20211202

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20221202

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20221202

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20231211

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20240910

Start annual number: 10

End annual number: 10